{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:00Z","timestamp":1791286620508,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Aldosterone production in the adrenal zona glomerulosa is mainly regulated by angiotensin II, [K+], and ACTH. Genetic deletion of subunits of K+-selective leak (KCNK) channels TWIK-related acid sensitive K+-1 and\/or TWIK-related acid sensitive K+-3 in mice results in primary hyperaldosteronism, whereas mutations in the KCNJ5 (potassium inwardly rectifying channel, subfamily J, member 5) gene are implicated in primary hyperaldosteronism and, in certain cases, in autonomous glomerulosa cell proliferation in humans.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>The objective of the study was to investigate the role of KCNK3, KCNK5, KCNK9, and KCNJ5 genes in a family with primary hyperaldosteronism and early-onset hypertension.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods:<\/jats:title>\n                  <jats:p>Two patients, a mother and a daughter, presented with severe primary hyperaldosteronism, bilateral massive adrenal hyperplasia, and early-onset hypertension refractory to medical treatment. Genomic DNA was isolated and the exons of the entire coding regions of the above genes were amplified and sequenced. Electrophysiological studies were performed to determine the effect of identified mutation(s) on the membrane reversal potentials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Sequencing of the KCNJ5 gene revealed a single, heterozygous guanine to thymine (G \u2192 T) substitution at nucleotide position 470 (n.G470T), resulting in isoleucine (I) to serine (S) substitution at amino acid 157 (p.I157S). This mutation results in loss of ion selectivity, cell membrane depolarization, increased Ca2+ entry in adrenal glomerulosa cells, and increased aldosterone synthesis. Sequencing of the KCNK3, KCNK5, and KCNK9 genes revealed no mutations in our patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>These findings explain the pathogenesis in a subset of patients with severe hypertension and implicate loss of K+ channel selectivity in constitutive aldosterone production.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2012-1334","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T21:55:15Z","timestamp":1338328515000},"page":"E1532-E1539","source":"Crossref","is-referenced-by-count":120,"title":["A Novel Point Mutation in the KCNJ5 Gene Causing Primary Hyperaldosteronism and Early-Onset Autosomal Dominant Hypertension"],"prefix":"10.1210","volume":"97","author":[{"given":"Evangelia","family":"Charmandari","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Diabetes (E.C., A.S., C.M., G.P.C.), Athens 11527, Greece"},{"name":"First Department of Pediatrics, University of Athens Medical School, \u2018Aghia Sophia\u2019 Children's Hospital, and Division of Endocrinology and Metabolism (E.C., A.S., G.P.C.), Clinical Research Center, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Sertedaki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Diabetes (E.C., A.S., C.M., G.P.C.), Athens 11527, Greece"},{"name":"First Department of Pediatrics, University of Athens Medical School, \u2018Aghia Sophia\u2019 Children's Hospital, and Division of Endocrinology and Metabolism (E.C., A.S., G.P.C.), Clinical Research Center, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoshige","family":"Kino","sequence":"additional","affiliation":[{"name":"Unit on Molecular Hormone Action (T.K.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Merakou","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Diabetes (E.C., A.S., C.M., G.P.C.), Athens 11527, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dax A.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Molecular Neurophysiology and Biophysics Unit (D.A.H., M.M.H., L.L.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Hatch","sequence":"additional","affiliation":[{"name":"Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Molecular Neurophysiology and Biophysics Unit (D.A.H., M.M.H., L.L.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell E.","family":"Hurt","sequence":"additional","affiliation":[{"name":"Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bioinformatics and Computational Biosciences Branch (D.E.H.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Molecular Neurophysiology and Biophysics Unit (D.A.H., M.M.H., L.L.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Xekouki","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Synaptic Neurophysiology, and Program in Developmental Endocrinology and Genetics (P.X., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Synaptic Neurophysiology, and Program in Developmental Endocrinology and Genetics (P.X., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Diabetes (E.C., A.S., C.M., G.P.C.), Athens 11527, Greece"},{"name":"First Department of Pediatrics, University of Athens Medical School, \u2018Aghia Sophia\u2019 Children's Hospital, and Division of Endocrinology and Metabolism (E.C., A.S., G.P.C.), Clinical Research Center, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071616260794900_B1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion.","volume":"50","author":"Quinn","year":"1988","journal-title":"Annu Rev Physiol"},{"key":"2020071616260794900_B2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0039-128X(94)00021-4","article-title":"Aldosterone: the minority hormone of the adrenal cortex.","volume":"60","author":"M\u00fcller","year":"1995","journal-title":"Steroids"},{"key":"2020071616260794900_B3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways.","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"key":"2020071616260794900_B4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2020071616260794900_B5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.10.046","article-title":"Glomerulosa cell\u2014a unique sensor of extracellular K+ concentration.","volume":"217","author":"Sp\u00e4t","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2020071616260794900_B6","first-page":"527","article-title":"The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man.","volume":"49","author":"Hollenberg","year":"1975","journal-title":"Clin Sci Mol Med"},{"key":"2020071616260794900_B7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1995.tb01850.x","article-title":"Potassium-angiotensin interplay in the regulation of aldosterone biosynthesis.","volume":"42","author":"Vallotton","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616260794900_B8","first-page":"F674","article-title":"A role for T-type Ca2+ channels in the synergistic control of aldosterone production by ANG II and K+.","volume":"276","author":"Chen","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071616260794900_B9","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1210\/endo.138.10.5463","article-title":"Effects of K+ channel blockers on K+ channels, membrane potential, and aldosterone secretion in rat adrenal zona glomerulosa cells.","volume":"138","author":"Lotshaw","year":"1997","journal-title":"Endocrinology"},{"key":"2020071616260794900_B10","first-page":"863","article-title":"TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II.","volume":"14","author":"Czirj\u00e1k","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2020071616260794900_B11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/mend.16.3.0788","article-title":"TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells.","volume":"16","author":"Czirj\u00e1k","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071616260794900_B12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0029-1243601","article-title":"TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation.","volume":"42","author":"Bandulik","year":"2010","journal-title":"Horm Metab Res"},{"key":"2020071616260794900_B13","first-page":"22","article-title":"The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas.","volume":"73","author":"Nogueira","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616260794900_B14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"2020071616260794900_B15","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071616260794900_B16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"2020071616260794900_B17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/ERC-12-0022","article-title":"KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"2020071616260794900_B18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction.","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"2020071616260794900_B19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1180310","article-title":"Crystal structure of the eukaryotic strong inward-rectifier K+ channel Kir2.2 at 3.1 A resolution.","volume":"326","author":"Tao","year":"2009","journal-title":"Science"},{"key":"2020071616260794900_B20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/bioinformatics\/btq066","article-title":"How significant is a protein structure similarity with TM-score = 0.5?","volume":"26","author":"Xu","year":"2010","journal-title":"Bioinformatics"},{"key":"2020071616260794900_B21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng"},{"key":"2020071616260794900_B22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles.","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol Rev"},{"key":"2020071616260794900_B23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment.","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"key":"2020071616260794900_B24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2011.180","article-title":"Adrenal gland: a diagnostic algorithm-the holy grail of primary aldosteronism.","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2020071616260794900_B25","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"2020071616260794900_B26","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616260794900_B27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2007-0030","article-title":"A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.","volume":"29","author":"Connell","year":"2008","journal-title":"Endocr Rev"},{"key":"2020071616260794900_B28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"key":"2020071616260794900_B29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","article-title":"Glucocorticoid-remediable aldosteronism.","volume":"40","author":"Halperin","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071616260794900_B30","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","article-title":"Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree.","volume":"87","author":"Mulatero","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616260794900_B31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","article-title":"Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.","volume":"18","author":"Fallo","year":"2004","journal-title":"J Hum Hypertens"},{"key":"2020071616260794900_B32","first-page":"3214","article-title":"Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.","volume":"83","author":"Torpy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616260794900_B33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1590\/S0100-879X2000001000004","article-title":"Familial hyperaldosteronism.","volume":"33","author":"Torpy","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"2020071616260794900_B34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071616260794900_B35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0039-128X(94)00013-3","article-title":"Primary aldosteronism\u2014some genetic, morphological, and biochemical aspects of subtypes.","volume":"60","author":"Gordon","year":"1995","journal-title":"Steroids"},{"key":"2020071616260794900_B36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism.","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"2020071616260794900_B37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1043-2760(98)00058-7","article-title":"Familial forms broaden the horizons for primary aldosteronism.","volume":"9","author":"Gordon","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"2020071616260794900_B38","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.","volume":"26","author":"Sukor","year":"2008","journal-title":"J Hypertens"},{"key":"2020071616260794900_B39","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring non-glucocorticoid remediable aldosteronism.","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616260794900_B40","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2008-1241","article-title":"A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/8\/E1532\/9040692\/jcem1532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/8\/E1532\/9040692\/jcem1532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:14:35Z","timestamp":1594955675000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/8\/E1532\/2823119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-1334","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,1]]}}}